☰

Jude Samulski, PhD

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
AAV, Parvovirology, Vector Development, Gene Therapy
Google:
"Jude Samulski"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Nicolas Muzyczka grad student UF Gainesville
Kenneth I. Berns post-doc UNC Chapel Hill

Children

Sign in to add trainee
Weidong Xiao grad student UNC Chapel Hill
Xiao Xiao grad student UNC Chapel Hill
Terry J. Amiss grad student 2001 UNC Chapel Hill
Jackie L. Stilwell grad student 2002 UNC Chapel Hill
Stephen Snowdy grad student 2003 UNC Chapel Hill
Vivian W. Choi grad student 2005 UNC Chapel Hill
Jarrod S. Johnson grad student 2009 UNC Chapel Hill
Angela M. Mitchell grad student 2013 UNC Chapel Hill
Steven J. Gray post-doc 2006-2008 UNC Chapel Hill
Sahana Nagabhushan Kalburgi research scientist UNC Chapel Hill (Neurotree)

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang M, Crosby A, Hastie E, et al. (2015) Prediction of adeno-associated virus neutralizing antibody activity for clinical application. Gene Therapy
Monahan PE, Sun J, Gui T, et al. (2015) Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Human Gene Therapy. 26: 69-81
Tremblay JP, Xiao X, Aartsma-Rus A, et al. (2013) Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 266-8
Bowles DE, McPhee SW, Li C, et al. (2012) Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 443-55
Kantor B, Bayer M, Ma H, et al. (2011) Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 547-56
Mendell JR, Campbell K, Rodino-Klapac L, et al. (2010) Dystrophin immunity in Duchenne's muscular dystrophy. The New England Journal of Medicine. 363: 1429-37
Weber M, Rabinowitz J, Provost N, et al. (2003) Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 774-81
Janson C, McPhee S, Bilaniuk L, et al. (2002) Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Human Gene Therapy. 13: 1391-412
See more...